Early Access — free while we kick the tires
EdgarHawk

MURPHY ANDREW J

EVP Research

Officer
1 filing analyzed · 1 company · Latest 2024-08-15

Companies

Company Buys Sells Direction
REGENERON PHARMACEUTICALS, INC. REGN 0 20 Net selling

Activity

August 2024
medium
Sell
6,363 shares
$7,337,505
Significance 4/10

EVP Andrew J Murphy sold 6,363 shares of REGN for $7,337,504.87 across 18 transactions on 2024-08-14

Murphy executed 18 separate sales totaling 6,363 shares for $7,337,504.87, reducing his holdings from 54,669 to 48,306 shares (-11.6% reduction). The transactions occurred at prices ranging from $1,140.31 to $1,158.78, with a blended average of $1,153.15, near the current price of $1,175.33 and within 0.0% of the 52-week high. His prior five sales at REGN (all on 2024-03-14) each showed negative 30-day returns (-6.0% to -5.2%) followed by positive 90-day returns (+6.7% to +7.6%), establishing a pattern of sales that have not been well-timed at the 90-day mark; all 5 prior trades failed to capture the subsequent upside. This current sale occurs at historically elevated valuations (P/E 25.55) on a stock up 7.3% in 30 days and 19.6% in 90 days, but without a defined trigger (no FLAG indicating a 10b5-1 plan) the motivation remains undisclosed.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access